<DOC>
	<DOCNO>NCT00461604</DOCNO>
	<brief_summary>It report Baclofen appropriate tool therapeutic management Gastroesophageal Reflux Disease . To objectify gastroesophageal reflux combine pH-metry/impedance monitoring apply patient persistent reflux-associated symptom despite PPI-therapy ( 40mg esomeprazole 2 week ) . After provement pathological finding test PPI-dosage escalate double standard-dosage another week . In case persistent symptom another ph-metry/impedance monitoring perform . In case pathological finding additional baclofen administer therapeutic regime . After 3 month another ph-metry/impedance monitoring perform . At time point test questionnaire complete . Aim study evaluate influence high dosage PPI-therapy additional baclofen patient persistent symptom objectify gastroesophageal reflux .</brief_summary>
	<brief_title>High Dosage Esomeprazole Baclofen Therapy Gastroesophageal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>age 1870 year informed consent patient persistent refluxassociated symptom despite PPItherapy epilepsy synthetic liver diseases renal failure disability understand inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>gastroesophageal reflux disease</keyword>
	<keyword>baclofen</keyword>
	<keyword>impedance</keyword>
</DOC>